{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:11:21Z","timestamp":1791353481910,"version":"4.3.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11767-9","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:01:31Z","timestamp":1761040891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Management of CMV encephalitis with persistent CSF CMV DNA in a patient with HIV: a case report of successful treatment with ganciclovir\u2013foscarnet combination therapy"],"prefix":"10.1186","volume":"25","author":[{"given":"Elif","family":"Tanyel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cengizhan","family":"Tanyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Server Sena","family":"Ersar\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Seyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande Berk","family":"Cam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"11767_CR1","unstructured":"-Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV. National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America. Available at https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-opportunistic-infection. Accessed on Jul. 14, 2025. In."},{"issue":"8","key":"11767_CR2","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1007\/s00415-023-11735-w","volume":"270","author":"M -Reimer-Mcatee","year":"2023","unstructured":"-Reimer-Mcatee M, Ramirez D, Mcatee C, Granillo A, Hasbun R. Encephalitis in HIV-infected adults in the antiretroviral therapy era. J Neurol. 2023;270(8):3914\u201333. https:\/\/doi.org\/10.1007\/s00415-023-11735-w.","journal-title":"J Neurol"},{"issue":"1","key":"11767_CR3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12879-025-10926-2","volume":"25","author":"M -Fang","year":"2025","unstructured":"-Fang M, Miao M, Lin X, Wang W, Wang Q, Liu L, et al. Gastrointestinal cytomegalovirus infection in persons with HIV: a retrospective case series study. BMC Infect Dis. 2025;25(1):506. https:\/\/doi.org\/10.1186\/s12879-025-10926-2.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"11767_CR4","doi-asserted-by":"publisher","first-page":"468","DOI":"10.4102\/sajid.v37i1.468","volume":"37","author":"R -Spies","year":"2022","unstructured":"-Spies R, Joubert P, Chetty D, Dlamini S, Moosa MS. Multisystem cytomegalovirus end-organ disease in a patient with advanced HIV. S Afr J Infect Dis. 2022;37(1):468. https:\/\/doi.org\/10.4102\/sajid.v37i1.468.","journal-title":"S Afr J Infect Dis"},{"issue":"1","key":"11767_CR5","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s12879-018-3501-2","volume":"18","author":"P -Palma","year":"2018","unstructured":"-Palma P, Costa A, Duro R, Neves N, Abreu C, Sarmento A. Mononeuritis multiplex: an uncommon neurological manifestation of cytomegalovirus reactivation in an HIV-infected patient. BMC Infect Dis. 2018;18(1):554. https:\/\/doi.org\/10.1186\/s12879-018-3501-2.","journal-title":"BMC Infect Dis"},{"key":"11767_CR6","doi-asserted-by":"publisher","first-page":"104936","DOI":"10.1016\/j.jcv.2021.104936","volume":"142","author":"G -Handley","year":"2021","unstructured":"-Handley G, Pankow S, Bard JD, Yee R, Nigo M, Hasbun R. Distinguishing cytomegalovirus meningoencephalitis from other viral central nervous system infections. J Clin Virol. 2021;142:104936. https:\/\/doi.org\/10.1016\/j.jcv.2021.104936.","journal-title":"J Clin Virol"},{"issue":"3","key":"11767_CR7","doi-asserted-by":"publisher","first-page":"100052","DOI":"10.1016\/j.jve.2021.100052","volume":"7","author":"MR -Caplan","year":"2021","unstructured":"-Caplan MR, Wilson EMP, Schechter M, Cai CW, Venner A, Bishop R, et al. High prevalence of Gastrointestinal manifestations among cytomegalovirus end-organ disease in the combination antiretroviral era. J Virus Erad. 2021;7(3):100052. https:\/\/doi.org\/10.1016\/j.jve.2021.100052.","journal-title":"J Virus Erad"},{"issue":"4","key":"11767_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/09564624221124697","volume":"34","author":"RM -Lucas J\u00fanior","year":"2023","unstructured":"-Lucas J\u00fanior RM, Bogoni G, Reis Schneider GA, Castanheira de Souza NF, Carvalho MK, Vidal JE. AIDS-related cytomegalovirus encephalitis in the late ART era: a retrospective cohort study at a referral center in Brazil. Int J STD AIDS. 2023;34(4):229\u201335. https:\/\/doi.org\/10.1177\/09564624221124697.","journal-title":"Int J STD AIDS"},{"issue":"6","key":"11767_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1590\/s0036-46652010000600004","volume":"52","author":"CA -Silva","year":"2010","unstructured":"-Silva CA, Oliveira AC, Vilas-Boas L, Fink MC, Pannuti CS, Vidal JE. Neurologic cytomegalovirus complications in patients with AIDS: retrospective review of 13 cases and review of the literature. Rev Inst Med Trop Sao Paulo. 2010;52(6):305\u201310. https:\/\/doi.org\/10.1590\/s0036-46652010000600004.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"2","key":"11767_CR10","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1212\/wnl.46.2.444","volume":"46","author":"BA -Cohen","year":"1996","unstructured":"-Cohen BA. Prognosis and response to therapy of cytomegalovirus encephalitis and meningomyelitis in AIDS. Neurology. 1996;46(2):444\u201350. https:\/\/doi.org\/10.1212\/wnl.46.2.444.","journal-title":"Neurology"},{"issue":"7","key":"11767_CR11","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s10096-004-1160-2","volume":"23","author":"I -Yust","year":"2004","unstructured":"-Yust I, Fox Z, Burke M, Johnson A, Turner D, Mocroft A, et al. Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in europe: a EuroSIDA study, 1994\u20132001. Eur J Clin Microbiol Infect Dis. 2004;23(7):550\u20139. https:\/\/doi.org\/10.1007\/s10096-004-1160-2.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"11767_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/jnnp.69.3.376","volume":"69","author":"M -Maschke","year":"2000","unstructured":"-Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry. 2000;69(3):376\u201380. https:\/\/doi.org\/10.1136\/jnnp.69.3.376.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"11767_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jinf.2007.10.005","volume":"56","author":"S -Sungkanuparph","year":"2008","unstructured":"-Sungkanuparph S, Chakriyanuyok T, Butthum B. Antiretroviral therapy in AIDS patients with CMV disease: impact on the survival and long-term treatment outcome. J Infect. 2008;56(1):40\u20133. https:\/\/doi.org\/10.1016\/j.jinf.2007.10.005.","journal-title":"J Infect"},{"issue":"4","key":"11767_CR14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11894-008-0077-9","volume":"10","author":"AL -Baroco","year":"2008","unstructured":"-Baroco AL, Oldfield EC. Gastrointestinal cytomegalovirus disease in the immunocompromised patient. Curr Gastroenterol Rep. 2008;10(4):409\u201316. https:\/\/doi.org\/10.1007\/s11894-008-0077-9.","journal-title":"Curr Gastroenterol Rep"},{"key":"11767_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jns.2018.02.029","volume":"388","author":"A -Baghban","year":"2018","unstructured":"-Baghban A, Malinis M. Ganciclovir and Foscarnet dual-therapy for cytomegalovirus encephalitis: a case report and review of the literature. J Neurol Sci. 2018;388:28\u201336. https:\/\/doi.org\/10.1016\/j.jns.2018.02.029.","journal-title":"J Neurol Sci"},{"issue":"3","key":"11767_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/clpt.1986.177","volume":"40","author":"C -Fletcher","year":"1986","unstructured":"-Fletcher C, Sawchuk R, Chinnock B, de Miranda P, Balfour HH Jr. Human pharmacokinetics of the antiviral drug DHPG. Clin Pharmacol Ther. 1986;40(3):281\u20136. https:\/\/doi.org\/10.1038\/clpt.1986.177.","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"11767_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s002800050916","volume":"43","author":"BM -Serabe","year":"1999","unstructured":"-Serabe BM, Murry DJ, Dauser R, Nuchtern J, Durfee J, McGuffey L, et al. Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primates. Cancer Chemother Pharmacol. 1999;43(5):415\u20138. https:\/\/doi.org\/10.1007\/s002800050916.","journal-title":"Cancer Chemother Pharmacol"},{"key":"11767_CR18","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1128\/AAC.37.5.1010","volume":"37","author":"UR -Hengge","year":"1993","unstructured":"-Hengge UR, Brockmeyer NH, Malessa R, Ravens U, Goos M. Foscarnet penetrates the blood\u2013brain barrier: rationale for therapy of cytomegalovirus encephalitis. Antimicrob Agents Chemother. 1993;37:1010\u20134.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"11767_CR19","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1128\/AAC.37.9.1777","volume":"37","author":"F -Raffi","year":"1993","unstructured":"-Raffi F, Taburet AM, Ghaleh B, Huart A, Singlas E. Penetration of Foscarnet into cerebrospinal fluid of AIDS patients. Antimicrob Agents Chemother. 1993;37(9):1777\u201380. https:\/\/doi.org\/10.1128\/AAC.37.9.1777.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"11767_CR20","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.transproceed.2016.01.021","volume":"48","author":"GW Kang","year":"2016","unstructured":"Kang GW, Hong HL, Lee IH, Ahn KS, Kim JD, Choi DL. Ganciclovir and foscarnet therapy of cytomegalovirus-associated meningoencephalitis in a hemodialysis patient with liver transplantation: case report. Transplant Proc. 2016;48(4):1208\u201311. https:\/\/doi.org\/10.1016\/j.transproceed.2016.01.021.","journal-title":"Transplant Proc."},{"issue":"4","key":"11767_CR21","doi-asserted-by":"publisher","first-page":"e58230","DOI":"10.7759\/cureus.58230","volume":"16","author":"A -Finessi","year":"2024","unstructured":"-Finessi A, Aziz MA, Izquierdo-Pretel G, Bracho A. Cytomegalovirus (CMV) polyradiculopathy: an important AIDS-defining illness complication. Cureus. 2024;16(4):e58230. https:\/\/doi.org\/10.7759\/cureus.58230.","journal-title":"Cureus"},{"issue":"5","key":"11767_CR22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/00002030-200003310-00007","volume":"14","author":"BM -Anduze-Faris","year":"2000","unstructured":"-Anduze-Faris BM, Fillet AM, Gozlan J, Lancar R, Boukli N, Gasnault J, et al. Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients. AIDS. 2000;14(5):517\u201324. https:\/\/doi.org\/10.1097\/00002030-200003310-00007.","journal-title":"AIDS"},{"key":"11767_CR23","unstructured":"-European AIDS, Clinical Society (EACS). EACS Guidelines version 12.1, 2024. https:\/\/eacs.sanfordguide.com"},{"issue":"Suppl 2","key":"11767_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/13550280290167957","volume":"8","author":"P -Cinque","year":"2002","unstructured":"-Cinque P, Bossolasco S, Bestetti A, Sala S, Pierotti C, Lazzarin A. Molecular studies of cerebrospinal fluid in human immunodeficiency virus type 1-associated opportunistic central nervous system diseases: an update. J Neurovirol. 2002;8(Suppl 2):122\u20138.","journal-title":"J Neurovirol"},{"issue":"8","key":"11767_CR25","doi-asserted-by":"publisher","first-page":"e249902","DOI":"10.1136\/bcr-2022-249902","volume":"15","author":"E -Kawegere","year":"2022","unstructured":"-Kawegere E, Goldberg T. Atypical presentation and diagnosis of AIDS-related CMV encephalitis. BMJ Case Rep. 2022;15(8):e249902. https:\/\/doi.org\/10.1136\/bcr-2022-249902.","journal-title":"BMJ Case Rep"},{"issue":"6","key":"11767_CR26","doi-asserted-by":"publisher","first-page":"e2022326","DOI":"10.23750\/abm.v93i6.13464","volume":"93","author":"J -Daodu","year":"2022","unstructured":"-Daodu J, Basuli D, Parikh A. A rare case of AIDS co-infected with COVID-19 presenting with disseminated herpes Zoster complicated with CMV and varicella Zoster virus meningoencephalitis. Acta Biomed. 2022;93(6):e2022326. https:\/\/doi.org\/10.23750\/abm.v93i6.13464.","journal-title":"Acta Biomed"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11767-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11767-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11767-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:01:34Z","timestamp":1761040894000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11767-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11767"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11767-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7262725\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1355"}}